- Home
- HITI vs OCGN Comparison
HITI vs OCGN Comparison
Compare HITI & OCGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HITI
- OCGN
- Stock Information
- Founded
- HITI 2009
- OCGN 2013
- Country
- HITI Canada
- OCGN United States
- Employees
- HITI N/A
- OCGN N/A
- Industry
- HITI
- OCGN Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- HITI
- OCGN Health Care
- Exchange
- HITI Nasdaq
- OCGN Nasdaq
- Market Cap
- HITI 217.9M
- OCGN 189.6M
- IPO Year
- HITI N/A
- OCGN N/A
- Fundamental
- Price
- HITI $1.97
- OCGN $0.65
- Analyst Decision
- HITI Strong Buy
- OCGN Strong Buy
- Analyst Count
- HITI 1
- OCGN 3
- Target Price
- HITI $4.50
- OCGN $6.33
- AVG Volume (30 Days)
- HITI 565.7K
- OCGN 4.1M
- Earning Date
- HITI 03-17-2025
- OCGN 03-05-2025
- Dividend Yield
- HITI N/A
- OCGN N/A
- EPS Growth
- HITI N/A
- OCGN N/A
- EPS
- HITI N/A
- OCGN N/A
- Revenue
- HITI $370,825,186.00
- OCGN $4,054,999.00
- Revenue This Year
- HITI $15.21
- OCGN N/A
- Revenue Next Year
- HITI $19.42
- OCGN N/A
- P/E Ratio
- HITI N/A
- OCGN N/A
- Revenue Growth
- HITI 7.84
- OCGN N/A
- 52 Week Low
- HITI $1.57
- OCGN $0.52
- 52 Week High
- HITI $3.62
- OCGN $2.08
- Technical
- Relative Strength Index (RSI)
- HITI 34.42
- OCGN 49.59
- Support Level
- HITI $1.80
- OCGN $0.69
- Resistance Level
- HITI $2.08
- OCGN $0.80
- Average True Range (ATR)
- HITI 0.12
- OCGN 0.06
- MACD
- HITI -0.01
- OCGN 0.02
- Stochastic Oscillator
- HITI 25.37
- OCGN 46.39
About HITI High Tide Inc.
High Tide Inc is a downstream-focused retailer of cannabis products, distributor, and seller of smoking accessories and cannabis lifestyle products. It is a vertically integrated company in the Canadian cannabis market with various brands in its portfolio such as Canna Cabana, Fastendr, Queen of Bud, Grasscity, Daily High Club, Famous Brandz, and others. The company's reportable operating segments are; Bricks and mortar which generates maximum revenue, and E-commerce. Geographically, it derives maximum revenue from its business in Canada followed by the United States of America, and other international markets.
About OCGN Ocugen Inc.
Ocugen Inc company focused on discovering, developing, and commercializing novel gene and cell therapies and vaccines that improve health and offer hope for patients across the globe. The company's pipeline includes Modifier Gene Therapy Platform, Novel Biologic Therapy for Retinal Diseases, Regenerative Medicine Cell Therapy Platform. The company is developing a modifier gene therapy platform designed to fulfill unmet medical needs related to retinal diseases, including inherited retinal diseases ("IRDs"), such as RP, LCA, Stargardt disease, and multifactorial diseases such as dAMD and Geographic Atrophy ("GA").